Tyner, Katherine M.
United States Food and Drug Administration · Center for Drug Evaluation and Research
4 papers on CoChatORCID 0000-0003-3812-6381
Most cited papers
- Verified
Liposomal drug product development and quality: current US experience and perspective
Kapoor, M., Lee, S. L., & Tyner, K. M. (2017) · The AAPS Journal
Nanoparticle-Based Drug DeliveryAnalytical Methods in Pharmaceuticals
Cited by 116
- Verified
Report of the AAPS Guidance Forum on the FDA draft guidance for industry:“drug products, including biological products, that contain nanomaterials”
de Vlieger, J. S. B., Crommelin, D. J. A., Tyner, K., Drummond, D. C., Jiang, W., McNeil, S. E., Neervannan, S., Crist, R. M., & Shah, V. P. (2019) · The AAPS Journal
Nanoparticle-Based Drug DeliveryPharmaceutical studies and practices
Cited by 100
- Verified
How has CDER prepared for the nano revolution? A review of risk assessment, regulatory research, and guidance activities
Tyner, K. M., Zheng, N., Choi, S., Xu, X., Zou, P., Jiang, W., Guo, C., & Cruz, C. N. (2017) · The AAPS Journal
Nanoparticle-Based Drug DeliveryNanotechnology research and applications
Cited by 33
- Verified
Summary report of PQRI workshop on nanomaterial in drug products: current experience and management of potential risks
Bartlett, J. A., Brewster, M., Brown, P., Cabral-Lilly, D., Cruz, C. N., David, R., Eickhoff, W. M., Haubenreisser, S., Jacobs, A., Malinoski, F., et al. (2015) · The AAPS Journal
Nanoparticle-Based Drug DeliveryNanotechnology research and applications
Cited by 25
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free